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Background: The aim of the present study was to compare the prevalence of periodontitis and alveolar bone loss
among individuals with psoriasis and a group of randomly selected controls.
Methods: Fifty individuals with psoriasis and 121 controls completed a structured questionnaire, and were
examined clinically and radiographically. Oral examination included numbers of missing teeth, probing pocket
depth (PPD), clinical attachment level (CAL), presence of dental plaque and bleeding on probing, as well as alveolar
bone loss from radiographs. Questionnaires requested information on age, gender, education, dental care, smoking
habits, general diseases and medicament use. For adjustment for baseline differences between psoriasis individuals
and controls the propensity score based on gender, age and education was computed using multivariate logistic
regression. A subsample analysis for propensity score matched psoriasis individuals (n = 50) and controls (n = 50)
was performed.
Results: When compared with controls, psoriasis individuals had significantly more missing teeth and more sites
with plaque and bleeding on probing. The prevalence of moderate and severe periodontitis was significantly
higher among psoriasis individuals (24%) compared to healthy controls (10%). Similarly, 36% of psoriasis cases had
one or more sites with radiographic bone loss ≥3 mm, compared to 13% of controls. Logistic regression analysis
showed that the association between moderate/severe periodontitis and psoriasis remained statistically significant
when adjusted for propensity score, but was attenuated when smoking was entered into the model. The
association between psoriasis and one or more sites with bone loss ≥3 mm remained statistically significant when
adjusted for propensity score and smoking and regularity of dental visits. In the propensity score (age, gender and
education) matched sample (n = 100) psoriasis remained significantly associated with moderate/severe periodontitis
and radiographic bone loss.
Conclusions: Within the limits of the present study, periodontitis and radiographic bone loss is more common
among patients with moderate/severe psoriasis compared with the general population. This association remained
significant after controlling for confounders.
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Periodontitis is a chronic inflammatory infectious dis-
ease characterized by an immunologically moderated de-
struction of dental supporting tissues [1]. The disease
affects more than 50% of adults in USA, and 5 – 10%
are so severely affected that they will lose one or more
teeth [2]. Psoriasis is a chronic, inflammatory, multi-system
disease with predominantly skin and joint manifestations* Correspondence: rasas@odont.uio.no
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Plaque psoriasis is the most common form of the disease,
affecting 80-90% of the patients [3]. The microscopic alter-
ations of psoriatic plaques include an infiltration of im-
mune cells in the dermis and epidermis, a dilatation and
an increase in the number of blood vessels in the upper
dermis, and a massively thickened epidermis with atypical
keratinocyte differentiation. It has been suggested that the
immune system plays an important role in the pathogen-
esis of psoriasis [4]. A long-standing focus on possible as-
sociations between periodontitis and general diseases [5]ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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studies, suggesting a link between these two chronic, in-
flammatory conditions.
Two recent epidemiological studies reported that peri-
odontitis may be an independent risk factor for develop-
ing psoriasis. In a prospective study among nurses in the
USA by NAKIB et al. [6], self-reported periodontal bone
loss was shown to be associated with an increased psor-
iasis incidence. According to the study authors, data on
a history of periodontal bone loss of nurses was col-
lected by mailed questionnaires and used as a proxy for
periodontal disease in the study. Similarly, increased risk
for psoriasis was found among patients with chronic
periodontitis diagnosis based on data from Health Insur-
ance Database in Taiwan [7]. The few available clinical
studies reported that individuals with psoriasis have a
significantly higher number of missing teeth, more se-
vere periodontitis and lower mean alveolar bone level
than controls [8,9]. Similarly, individuals with psoriatic
arthritis had more clinical attachment loss compared to
age and gender matched healthy controls [10], but, after
adjustment for confounders [8,10], none of the studies
reported an association between clinical or radiographic
periodontitis parameters and psoriasis.
One suggested biological explanation for the associ-
ation between the two diseases is that psoriasis and peri-
odontitis may be associated due to common underlying
pathologic conditions [11-14]. Periodontal plaque has
several polyclonal and mitotic factors that may trigger
autoimmune antibodies which in turn may cause skin le-
sions or vice-versa. Characteristic for both psoriasis and
periodontitis is an exaggerated immune response to the
microbiota residing at the epithelial surface. For instance,
dendritic cells (DC) are important for the initiation and
regulation of both innate and adaptive immunity, and
form a bridge between the two immune systems by traf-
ficking from the epithelial barriers to the regional lymph
nodes [15,16]. In both psoriasis and periodontitis, DC may
play an important role in driving the exaggerated immune
response [4,16,17].
On the other hand, other important factors may play
significant roles and confound the association between
periodontitis and psoriasis [18]. Several studies have re-
ported that psoriasis is associated with both physical and
psychological comorbidity, and may therefore have a sig-
nificant impact on the educational and work activities of
the patients [19,20]. Moreover, psoriasis patients have
impaired health-related quality of life, which may lead to
unhealthy lifestyle behaviours such as smoking, alcohol
consumption, decreased physical activity and obesity
[21]. Several of these factors are associated with in-
creased risk of periodontitis [22]. Thus it is essential that
relevant background and behavioural variables, which
may confound the association between periodontitis andpsoriasis, are taken into account, however, to our know-
ledge, no previous studies controlled for socioeconomic
status (education) of participants or dental attendance.
Despite the increased focus on the topic during recent
years, there are very few clinical studies on association
between periodontitis and psoriasis and existing evi-
dence is inconsistent. It might be speculated, that in case
the two diseases are related, the association would be
stronger in individuals with more severe psoriasis. Thus,
the aim of the present study was to compare prevalence
of periodontitis and alveolar bone loss among individuals
with moderate to severe psoriasis and a group of ran-
domly selected controls, and to assess whether the asso-
ciation is sustained after adjustment for confounding
factors.
Methods
The present study was approved by the Regional
Committee for Medical and Health Research Ethics,
(REC- South-East (#2010/401) and conducted from
October 2011 until December 2012 at the Faculty of
Dentistry, University of Oslo and the Dermatology
Department, Oslo University Hospital-Rikshospitalet,
Norway.
Study participants
Sample size was determined based on the assumption
that the expected prevalence of periodontitis is 30%
among individuals with psoriasis compared to 10%
among otherwise healthy controls [23]. The calculations
were performed using Fleiss method at OpenEpi open
source software [24]. Based on a significance level of
0.05, power of 90% and 1:2 ratio of cases to controls, it
was decided to include 120 healthy controls and 60 indi-
viduals with psoriasis in the study. A higher number of
controls compared to psoriasis individuals were selected
in order to increase the study power.
Individuals with psoriasis were consecutively recruited
from the Department of Dermatology, Oslo University
Hospital-Rikshospitalet, Norway. Sixty five individuals
received invitation to participate during their regular
visit to the dermatological department or from the in-
patient unit. Their psoriasis diagnosis was verified by a
resident dermatologist (EMS) using Psoriasis Area and
Severity Index (PASI) [25]. This index is based on the
degree of erythema, infiltration and scaling (respectively:
0 = none, 1 =mild, 2 =moderate, 3 = severe, 4 = very se-
vere) and the extent of involvement of four body skin
areas (head, trunk, arms and legs). According to European
consensus definitions, plaque psoriasis is graded into mild
and moderate to severe disease [26]. Psoriasis is classified
as mild if the PASI is below 10, and moderate to severe if
it is 10 or above. Patients with a PASI score ≥10 or on-
going systemic or biologic treatment were considered to
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to attend for clinical and radiographic periodontal examin-
ation at the Faculty of Dentistry, University of Oslo.
The inclusion criteria were individuals 18 – 65 years of
age, who had suffered from moderate to severe psoriasis
for more than five years (see above definition). Persons
with known familiar hypercholesterolemia, concomitant
inflammatory diseases such as infections, autoimmune
disorders, malignancies and pregnancy were excluded.
After subsequent invitation by telephone, 51 accepted the
invitation and attended the study (79% response rate).
During the clinical examination one of the patients was
found to be edentulous and was excluded, leaving 50 indi-
viduals with moderate or severe psoriasis for further
analysis.
The control sample was obtained from a list provided
by the Norwegian National Population Register contain-
ing one thousand randomly selected 35-65-yr-old indi-
viduals, from the greater Oslo area. A smaller random
sample of 400 individuals was selected in a two stage
procedure (200 individuals at each stage) and invited to
participate in the study. Only participants born in
Norway or a Western country were selected. Of the 242
eligible individuals, 125 attended the study (response
rate 52%) (Figure 1). After excluding three participants
because of self reported psoriasis as well as one edentu-
lous individual, the final study sample comprised 121Figure 1 Flow chart of the study population.controls. Of those who refused to participate, 56% of
controls and 50% of psoriasis individuals agreed to be
telephone interviewed about their education, dental
health related behavior, smoking habits and reason for
not attending the study. Twenty per cent of the non-
responders among controls reported that they had been
diagnosed with gum disease. Comparisons of the partici-
pants and the non-attenders in relation to available
background characteristics revealed that there were
more current smokers among the non-responders in the
control group. In contrast, a lower number of the non-
attenders reported that they were current smokers (14%
versus 32%) compared with the participants in the psor-
iasis group.
Data collection
All participants received written information about the
study and signed an informed consent. Data collection
included self-administered questionnaires as well as clin-
ical and radiographical examination at the Institute of
Clinical Dentistry, Faculty of Dentistry. The structured
questionnaire included background information (age,
gender and education), information on dental care and
dental attendance, smoking, self reported general dis-
eases, and medicament use. All items in the question-
naire had closed ended questions, except for age, self
reported diseases and medicament use, weight and height,
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corded as 1) lower secondary education or less, 2)
upper secondary or 3) higher education. For regres-
sion analyses, the education variable was dichoto-
mized into higher education versus upper secondary
or lower education. Smoking status was recorded as
never-, former- or current smokers. For regression
analyses, the variable was dichotomized into current
versus former and never smokers.
Clinical examination included numbers of missing
teeth, assessment of probing pocket depth (PPD) and
clinical attachment level (CAL) in mm, performed with
an LM 52B probe (LM-Instruments Oy, Finland). PPD,
CAL as well as the presence of dental plaque (yes/no)
and bleeding on probing (BOP) (yes/no) were recorded
at four surfaces (MB, B, DB, P/L) of all teeth present, ex-
cept for the third molars. For statistical analyses, the re-
cordings were computed into the proportion of sites
with plaque or BOP. The clinical examination was per-
formed by two trained examiners. The first examiner
(RSR) recorded presence of plaque, BOP and PPD, whereas
the second (BFH) recorded CAL.
Periodontitis was defined according to the case defini-
tions for surveillance of periodontitis proposed by the
Centers for Disease Control and Prevention (CDC) and
the American Academy of Periodontology (AAP) [27].
Moderate periodontitis was defined as having ≥2 inter-
proximal sites with AL ≥4 mm (not on same tooth), or ≥2
interproximal sites with PPD ≥5 mm (not on same tooth).
Severe periodontitis was defined as having ≥2 interproxi-
mal sites with AL ≥6 mm (not on same tooth) and ≥1 in-
terproximal site with PPD ≥5 mm. Individuals who had
moderate or severe periodontitis according to the defin-
ition, were considered to have the disease.
Six intra-oral digital radiographs, two bitewings on
each side and two periapical radiographs of the incisors
of both jaws, were taken using Kwik-Bite bite-wing
holders (Kerr Corporation, West Collins Orange, CA,
USA) and Eggens (Eggen X-ray, Lillehammer, Norway)
film holders. Radiographs were obtained by the Digora
Digital imaging plate system film (Soredex, Finland ) and
a Planmeca intra (Planmeca Oy, Finland) X-ray unit.
The images were transferred and stored using Sectra
PACS (Sectra AB, Linköping, Sweden) image server
digital storage system. The radiographs were magnified
using a computer, and radiographic bone loss was regis-
tered by one examiner (BFH) using the public domain
digital imaging program Image J (Image J, National
Institutes of Health, Bethesda, Maryland, USA). Bone
loss was registered when the distance from the cemento-
enamel junction (CEJ) to the alveolar crest (AC) exceeded
2 mm, in sites where CEJ and AC could be identified
clearly. The measurements were made in mm in the inter-
proximal areas of fully erupted canines, premolars, molars,upper central incisors and lower central and lateral incisors.
Participants with radiographic bone loss ≥3 mm at one or
more sites were considered as having the condition.
The radiographic examination was masked, i.e. the
examiner was unaware of if participants had psoriasis or
not, whereas the clinical examination could not be
regarded as masked since some patients harbored psor-
iasis lesions visible to the examiner.
The intra-examiner reproducibility of radiographic
bone loss was evaluated on the basis of repeat record-
ings radiographs from 20 randomly selected individuals
within a time frame of 14 days , the K-value being re-
corded to 0.61 for recordings of bone loss in mm and
0.75 for dichotomized outcome (bone loss present/ab-
sent) and deemed as good [28].
Statistical analyses
When comparing differences between the psoriasis and
the control groups, the Chi-square test was used for cat-
egorical variables, and the independent samples t-test
for continuous variables. In order to balance for differ-
ences in baseline characteristics between the psoriasis
individuals and the controls, a propensity score was cal-
culated for each person using logistic regression analysis,
regressing psoriasis status (0 = no psoriasis; 1 = psoriasis)
on the background characteristics (age, gender and edu-
cation) [29]. The propensity score was considered as in-
dividuals’ probability of having psoriasis, conditional on
the background covariates.
A subgroup of control individuals was then selected
based on the propensity score values and 1:1 matched to
individuals in the psoriasis group. This would allow to
compare individuals who based on observables have
more similar background characteristics (similar propen-
sity score), except for their psoriasis status.
The association between psoriasis and periodontitis
was investigated by using logistic regression analysis for
the initial eligible study sample and for the propensity
score matched sample. Variables significantly associated
with the outcome in bivariate analyses at p-value <0.05,
were entered into the regression analyses as independent
variables. Multicollinearity diagnostics for independent
variables was calculated using the Variance Inflation Fac-
tor (VIF) [30]. The VIF was <5 for all associations, indi-
cating absence of multicollinearity which may invalidate
the regression analysis. Results were reported as odds ra-
tios (OR) with 95% confidence intervals (CI). The level
of significance was set at 5%. Data were analyzed using
the SPSS statistical program package (IBM SPSS 20.0,
SPSS Inc., Chicago, IL, USA).
Results
In the psoriasis group, mean disease duration was
22.3 years (range 4 to 52 years), and mean age was 45 years
Skudutyte-Rysstad et al. BMC Oral Health 2014, 14:139 Page 5 of 9
http://www.biomedcentral.com/1472-6831/14/139(range 22 to 64 years). The controls had a mean age of
49 years (range 35 to 66 years). The mean propensity score
values were 0.51 (SD = 0.26) in the psoriasis group com-
pared to 0.79 (SD = 0.17) in the control group (p < 0.001).
After the selection of 50 controls most closely matching
psoriasis individuals based on the propensity score, the
mean propensity in the control group score was 0.63 (SD =
0.16), (p = 0.006).
Table 1 shows statistically significant differences be-
tween the psoriasis and the control group in relation to
gender, education, oral hygiene, dental attendance,
smoking habits and use of immunosuppressants. The
majority of the participants with psoriasis were under
medication at the time of investigation, and 68% re-
ported use of immunosuppressive drugs, compared with
2% in the control group. As shown in Table 1, baseline
characteristics of the psoriasis and control groups after
propensity score matching were not significantly differ-
ent, except for smoking and medicament use.
Three of the individuals with psoriasis had diabetes,
whereof two had radiographic bone loss ≥3 mm. One in-
dividual in the control group had diabetes and radio-
graphic bone loss ≥3 mm.
Participants with psoriasis had significantly higher
mean numbers of missing teeth and higher mean pro-
portions of sites with plaque and bleeding on probing
compared with the controls (Table 2). The prevalence of
periodontitis and the prevalence of radiographic boneTable 1 Background and behavioral characteristics of individ
All participants
Psoriasis individuals N = 50
Age (yr)
Mean (SD) 44.4 (10.2)
Female gender 24%
Education
Lower secondary or less 16%
Upper secondary 58%
Higher education 26%
Tooth brushing twice a day or more 58%
Daily interdental cleaning 30%
Regular dental visits 58%
Last dental visit ≤1 yr ago 62%
Smoking
Never smoked 22%
Former smoker 46%
Current smoker 32%
BMI ≥ 25 62%
Immunosuppressive medicaments 68%
*differences statistically significant at p < 0.05 level.loss was also significantly higher among individuals with
psoriasis compared with the controls. Similarly, differ-
ences in clinical and radiologic findings were observed
in the propensity score matched subsample.
Logistic regression analysis with adjustments for the
propensity score for the whole sample was performed in
order to assess whether the association between peri-
odontitis and psoriasis remained significant when con-
trolling for confounding. Two outcome variables were
investigated: moderate/severe periodontitis and one or
more sites with radiographic bone loss ≥3 mm. As
shown in Table 3, the association between moderate/se-
vere periodontitis and psoriasis remained statistically sig-
nificant when adjusted for propensity score, but was
attenuated when smoking was entered into the model.
Adjustment for regularity of dental visits did not change
the association. The association between psoriasis and
one or more sites with radiographic bone loss ≥3 mm
remained statistically significant when adjusted for pro-
pensity score and smoking and regularity of dental visits
(Table 4). In the propensity score matched sample psoria-
sis remained significantly associated with moderate/severe
periodontitis and radiographic bone loss (Tables 5 and 6).
Discussion
In the present study, the prevalence of radiographic bone
loss was significantly higher among psoriasis individuals
than the randomly selected controls. This associationuals with psoriasis and controls
Propensity score matched participants
Controls N = 121 Psoriasis individuals N = 50 Controls N = 50
48.6 (9.4)* 44.4 (10.2) 44.1 (8.1)
50%* 24% 32%
3% 16% 4%
28% 58% 54%
69%* 26% 42%
85%* 58% 78%
41% 30% 32%
89%* 58% 78%
82%* 62% 72%
47% 22% 52%
40% 46% 30%
13%* 32% 18%*
51% 62% 60%
2%* 68% 2%*
Table 2 Clinical and radiological findings in individuals with psoriasis and controls
All participants Propensity score matched participants
Psoriasis individuals N = 50 Controls N = 121 Psoriasis individuals N = 50 Controls N = 50
% of sites with PPD ≥4 mm
Mean (SD) 3.7 (4.1) 1.9 (3.8)* 3.7 (4.1) 2.2 (4.3)
% of sites with PPD ≥5 mm
Mean (SD) 1.5 (3.3) 0.6 (1.9)* 1.5 (3.3) 0.6 (2.1)
% of sites with CAL ≥ 2 mm
Mean (SD) 6.6 (9.5) 6.6 (8.8) 6.6 (9.5) 5.9 (6.7)
Mild periodontitis, % 18% 8% 18% 8%
Moderate or severe periodontitis, % 24% 10%* 24% 8%*
% of sites with bone loss ≥3 mm 4.6 (11.0) 0.9 (3.2)* 4.6 (11.0) 0.7 (2.3)*
Mean (SD)
One or more sites with bone loss ≥3 mm 36% 13%* 36% 10%*
Number of missing teeth
Mean (SD) 2.4 (3.9) 1.4 (2.5)* 2.4 (3.9) 1.1 (1.7)*
% of sites with plaque
Mean (SD) 41 (25) 29 (20)* 41 (25) 33 (19)
% of sites with bleeding on probing
Mean (SD) 37 (18) 24 (13)* 37(18) 26 (15)*
*differences statistically significant at p < 0.05 level.
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pensity score (age, gender and education) and controlling
for smoking, scores and regularity of dental visits. Simi-
larly, the prevalence of moderate to severe periodontitis
was significantly higher among psoriasis patients, but this
association was significant only in the propensity score
(age, gender and education) matched subsample.
These results support previously reported findings,
where individuals with psoriasis had significantly fewer
teeth and reduced bone level compared to controls [8,9].
However, contrary to the previous reports [8], the asso-
ciation between radiographic bone loss and psoriasis in
the present study remained significant after controllingTable 3 Odds ratios (95% confidence interval) for the
association of psoriasis and periodontitis, whole sample
(N = 171)
Model OR (95% CI) p B SE Wald df
Unadjusted 2.8 (1.2; 6.9) 0.019 1.054 0.450 5.493 1
Model 1a 3.0 (1.0; 8.5) 0.043 1.089 0.538 4.0953. 1
Model 2b 2.6 (0.9; 7.7) 0.079 0.963 0.548 090 1
Model 3c 2.7 (0.9; 8.0) 0.069 1.002 0.552 3.296 1
aModel 1: logistic regression analysis using periodontitis as dependent variable
and psoriasis status as independent variable, adjusted for propensity score.
bModel 2: as Model 1, except that smoking status was added as
independent variable.
cModel 3: as Model 2, except that regularity of dental visits was added as
independent variable.
Stepwise logistic regression analysis.for confounders. One of the possible explanations for
differences in the findings could be more severe degree of
psoriasis among participants investigated in the present
study.
The results of this study showed a significant associ-
ation between psoriasis and radiographic bone loss, as
well as the clinical periodontitis parameters. It may be
suggested that while radiographic bone loss indicates a
history of periodontal disease and reflects cumulative de-
struction over time, clinical periodontitis measurements
are affected by current tissue inflammation levels, which
on turn could be affected by smoking [31]. The fact that
the association between moderate/severe periodontitisTable 4 Odds ratios (95% confidence interval) for the
association of psoriasis and radiographic bone loss,
whole sample (N = 171)
Model OR (95% CI) p B SE Wald df
Unadjusted 3.7 (1.7; 8.1) 0.001 1.306 0.399 10.739 1
Model 1a 4.5 (1.7;11.5) 0.002 1.495 0.483 9.594 1
Model 2b 4.0 (1.6; 10.5) 0.004 1.394 0.489 8.136 1
Model 3c 4.0 (1.5; 10.4) 0.005 1.378 0.492 7.847 1
aModel 1: logistic regression analysis using radiographic bone loss as
dependent variable and psoriasis status as independent variable, adjusted for
propensity score.
bModel 2: as Model 1, except that smoking status was added as
independent variable.
cModel 3: as Model 2, except that regularity of dental visits was added as
independent variable.
Stepwise logistic regression analysis.
Table 5 Odds Ratios (95% confidence interval) for the
association of psoriasis and periodontitis, propensity
score matched sample (N = 100)
Model OR (95% CI) p B SE Wald df
Unadjusted 3.6 (1.1; 12.2) 0.037 1.290 0.618 4.361 1
Model 1a 3.1 (0.9; 10.8) 0.071 1.143 0.632 3.271 1
Model 2b 3.7 (1.0; 13.1) 0.047 1.297 0.652 3.960 1
aModel 1: logistic regression analysis using bone loss as dependent variable
and psoriasis status as independent variable, adjusted for smoking.
bModel 2: as Model 1, except that that regularity of dental visits was added as
independent variable.
Stepwise logistic regression analysis.
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into the regression model for the whole sample supports
this assumption.
Periodontitis is a cumulative condition and therefore
radiographic bone loss, capturing past history of disease,
was used in addition to the clinical registration of peri-
odontal status. Clinical examiners were not calibrated
which is a limitation of the present study. Contrary to
the clinical registration, bone loss measurements were
masked and therefore not exposed to the possibility that
psoriasis history of participants could affect our mea-
surements. According to the literature, the distance
from the CEJ to the alveolar crest at sites without clin-
ical loss of attachment ranges from 0.3 to 2.4 mm (mean
1.1, SD = 0.4), as measured on bite-wing radiographs
[32]. In order to avoid misclassification of borderline
values, bone loss ≥3 mm in interproximal sites was
chosen as a key outcome. The risk of overestimation of
bone loss on a specific site should therefore be elimi-
nated. We chose to define bone loss on one site as bone
loss caused by periodontitis, although in some rare in-
stances there may be other local factors causing bone
loss. On the other hand, because of unreadable sites,
due to overlapping of teeth, margins of fillings and
crowns etc., there is a risk of underestimating proximal
periodontal bone loss on radiographs.
The cross-sectional design of the study precludes any
causal interpretations of the observed associations. Since
all the participants were of Norwegian or WesternTable 6 Odds Ratios (95% confidence interval) for the
association of psoriasis and radiographic bone loss,
propensity score matched sample (N = 100)
Model OR (95% CI) p B SE Wald df
Unadjusted 5.0 (1.7; 15.1) 0.004 1.622 0.556 8.512 1
Model 1a 4.6 (1.5; 13.9) 0.007 1.522 0.565 7.266 1
Model 2b 4.5 (1.5; 13.7) 0.009 1.497 0.573 6.838 1
aModel 1: logistic regression analysis using bone loss as dependent variable
and psoriasis status as independent variable, adjusted for smoking.
bModel 2: as Model 1, except that that regularity of dental visits was added as
independent variable.
Stepwise logistic regression analysis.origin, generalization of our findings is limited to these
populations. The response rate in our study was lower
than anticipated, 79% in psoriasis group and 52% in con-
trol group. The comparisons of participants and non-
responders of the control group indicate that the two
groups were similar in socioeconomic, background and
dental habits, but there were more smokers among the
non-responders in the control group. According to Sta-
tistics Norway, 14% of 16-74-yr-olds in Oslo area in
2008-2012 are daily smokers, showing that the propor-
tion of smokers in the control group was similar to the
general population. In contrast, fewer non-attenders in
the psoriasis group reported that they were current
smokers. Since smoking affects periodontal health nega-
tively [33], it can be speculated that the true difference
in periodontal conditions between the psoriasis and con-
trol groups could be overestimated to some extent.
There were significant differences between psoriasis
cases and controls in relation to background and behav-
ioral variables. The propensity score adjustment was
used in order to balance the two groups in relation to
these differences. In addition to the adjustment in multi-
variate analyses, a propensity score matched analysis in a
subsample of 100 participants was performed. By select-
ing 50 controls and matching them to 50 psoriasis indi-
viduals by their propensity score, the two groups were
not statistically significant different in their background
characteristics, except for smoking. Multivariate analyses
for the whole sample and propensity score matched sub-
sample yielded similar results.
Although in multivariate analyses we adjusted for several
important confounders, the possibility of residual con-
founding cannot be ruled out. Therefore, larger population
based studies using broader sets of possible confounders
are warranted. Case-control studies of this type are also
more prone to confounding if the cases and controls are
selected from different populations. As patients at a hos-
pital clinic, the cases were likely to have more severe psor-
iasis compared to general population of psoriasis patients,
whereas the controls were selected from the general popu-
lation and less likely to have health problems. To overcome
this limitation, future studies should select cases and con-
trols from the same population, such as patients with and
without psoriasis at dermatology clinics.
The present study assessed periodontal conditions in
individuals with moderate and severe psoriasis with long
disease exposure time (mean 22 years), but, it remains un-
certain whether our findings can be generalized to individ-
uals with milder forms of psoriasis. Sixty-eight per cent of
the psoriasis patients were using immunosuppressive
medication. Several studies have shown that immunosup-
pressive drug therapy may reduce the inflammatory re-
sponses of the periodontal tissue to bacterial plaque [34].
However, in the present study, the anti-inflammatory
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not be seen. Psoriasis patients using immunosuppressive
medication had slightly lower number of bleeding sites
and prevalence of radiographic bone loss, but none of the
differences were statistically significant. One of the pos-
sible explanations could be that the periodontal destruc-
tion is a cumulative condition, while use of medication
was assessed at one time point. There is a possibility that
the exposure time to immunosuppressive medicaments
was too short to have an effect on periodontal destruction
parameters. Due to the fact, that there were too few psor-
iasis patients not using immunosuppressive drugs, our
study was not able to distinguish whether the observed
differences could be attributed to the psoriasis or was a
consequence of medicament use. Despite of that, our find-
ings suggest that health personnel in contact with psoriasis
patients, should be aware of and focus on periodontitis
prevention in this group.
Conclusions
Within the limits of the present study, results from the
present study support the notion that periodontitis and
radiographic bone loss are more common among pa-
tients with moderate/severe psoriasis compared with the
general population. Thus these findings may imply a
need for increased awareness and focus on periodontitis
prevention for individuals with psoriasis.
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